Department of Neuroradiology, Niguarda Hospital, Milan, Italy. mariangela.piano@gmail
J Neurosurg. 2013 Feb;118(2):408-16. doi: 10.3171/2012.10.JNS112222. Epub 2012 Nov 23.
The introduction of flow diverter devices is revolutionizing the endovascular approach to cerebral aneurysms. Midterm and long-term results of angiographic, cross-sectional imaging and clinical follow-up are still lacking. The authors report their experience with endovascular treatment of intracranial aneurysms using both the Pipeline embolization device and Silk stents.
From October 2008 to July 2011 a consecutive series of 104 intracranial aneurysms in 101 patients (79 female, 22 male; average age 53 years) were treated. Three of the 104 aneurysms were ruptured and 101 were unruptured. Silk stents were implanted in 47 of the aneurysms and Pipeline stents in the remaining 57. In 14 cases a combination of flow diverter devices and coils were used to treat larger aneurysms (maximum diameter > 15 mm). Patients underwent angiographic follow-up examination at 6 months after treatment, with or without CT or MRI, and at 1 year using CT or MRI, with or without conventional angiography.
In all cases placement of flow diverter stents was technically successful. The mortality and morbidity rates were both 3%. Adverse events without lasting clinical sequelae occurred in 20% of cases. Angiography performed at 6 months after treatment showed complete aneurysm occlusion in 78 of 91 cases (86% of evaluated aneurysms) and subocclusion in 11 (12%); only in 2 cases were the aneurysms unchanged. Fifty-three aneurysms were evaluated at 1 year after treatment. None of these aneurysms showed recanalization, and 1 aneurysm, which was incompletely occluded at the 6-month follow-up examination, was finally occluded. Aneurysmal sac shrinkage was observed in 61% of assessable aneurysms.
Parent artery reconstruction using flow diverter devices is a feasible, safe, and successful technique for the treatment of endovascular treatment of cerebral aneurysms.
血流导向装置的引入正在彻底改变颅内动脉瘤的血管内治疗方法。血管造影、横截面成像和临床随访的中期和长期结果仍然缺乏。作者报告了他们使用 Pipeline 栓塞装置和 Silk 支架对颅内动脉瘤进行血管内治疗的经验。
从 2008 年 10 月至 2011 年 7 月,连续治疗了 101 例 104 个颅内动脉瘤(79 例女性,22 例男性;平均年龄 53 岁)。其中 3 个动脉瘤破裂,101 个未破裂。47 个动脉瘤植入 Silk 支架,其余 57 个动脉瘤植入 Pipeline 支架。在 14 例病例中,使用血流导向装置和线圈的联合治疗来治疗更大的动脉瘤(最大直径>15mm)。所有患者均在治疗后 6 个月进行血管造影随访检查,有或无 CT 或 MRI,并在 1 年时使用 CT 或 MRI,有或无常规血管造影。
所有情况下,血流导向支架的放置技术均成功。死亡率和发病率均为 3%。无持久临床后遗症的不良事件发生率为 20%。治疗后 6 个月的血管造影显示,91 例可评估动脉瘤中的 78 例(78%)完全闭塞,11 例(12%)次全闭塞;仅 2 例动脉瘤未改变。53 个动脉瘤在治疗后 1 年进行了评估。这些动脉瘤均未出现再通,1 个在 6 个月随访检查时不完全闭塞的动脉瘤最终闭塞。61%的可评估动脉瘤出现了动脉瘤囊缩小。
使用血流导向装置重建载瘤动脉是治疗颅内动脉瘤的一种可行、安全和成功的技术。